0001104659-19-020854.txt : 20190513 0001104659-19-020854.hdr.sgml : 20190513 20190411160249 ACCESSION NUMBER: 0001104659-19-020854 CONFORMED SUBMISSION TYPE: CORRESP PUBLIC DOCUMENT COUNT: 1 FILED AS OF DATE: 20190411 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Zealand Pharma A/S CENTRAL INDEX KEY: 0001674988 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 000000000 STATE OF INCORPORATION: G7 FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: CORRESP BUSINESS ADDRESS: STREET 1: SMEDELAND 36 STREET 2: 2600 GLOSTRUP CITY: COPENHAGEN STATE: G7 ZIP: 00000 BUSINESS PHONE: 4588773600 MAIL ADDRESS: STREET 1: SMEDELAND 36 STREET 2: 2600 GLOSTRUP CITY: COPENHAGEN STATE: G7 ZIP: 00000 CORRESP 1 filename1.htm

 

Zealand Pharma A/S

Smedeland 36

2600 Glostrup (Copenhagen)

Denmark

 

VIA EDGAR

 

April 11, 2019

 

U.S. Securities and Exchange Commission

Division of Corporation Finance

100 F Street, N.E.

Washington, D.C. 20549

 

Attn:

 

Sonia Bednarowski

 

 

 

Re:

 

Zealand Pharma A/S

 

 

Registration Statement on Form F-3

 

 

File No. 333-230654

 

 

 

 

 

Acceleration Request

 

 

Requested Date:

Monday April 15, 2019

 

 

Requested Time:

4:00 P.M. Eastern Daylight Time

 

Ladies and Gentlemen:

 

In accordance with Rule 461 under the Securities Act of 1933, as amended, the undersigned registrant (the “Registrant”) hereby requests that the Securities and Exchange Commission (the “Commission”) take appropriate action to cause the above-referenced Registration Statement on Form F-3 (File No. 333-230654) (the “Registration Statement”) to become effective on April 15, 2019, at 4:00 p.m. Eastern Daylight Time, or as soon thereafter as is practicable, or at such later time as the Registrant may orally request via telephone call to the staff (the “Staff”).

 

The Registrant hereby authorizes each of Marc Recht, Josh Kaufman and Layne Jacobs of Cooley LLP to make such request on its behalf.

 

If you have any questions regarding this request, please contact Marc Recht of Cooley LLP at (617) 937-2316 or Josh Kaufman of Cooley LLP at (212) 479-6495.  Thank you for your assistance with this matter.

 

[Signature Page Follows]

 

 

Sincerely,

 

 

 

 

 

 

ZEALAND PHARMA A/S

 

 

 

 

 

 

 

 

 

 

By:

/s/ Ravinder Chahil

 

 

 

Ravinder Chahil

 

 

 

Vice President, General Counsel

 

 

 

 

 

 

 

 

 

 

cc:

 

Marc Recht, Cooley LLP

 

 

 

 

Josh Kaufman, Cooley LLP

 

 

 

 

Layne Jacobs, Cooley LLP